John A. Burns School of Medicine
Honolulu, HI 96813
United States
ARCS Honolulu invites you to a free hybrid Pau Hana talk
Ebola Vaccine Development During a Public Health Emergency
and Implications for Pandemic Preparedness
Featuring Dr. Beth-Ann Coller
Pupus from 5:30 p.m., Zoom room opens at 5:45; Talk begins at 6 p.m.
The expanding, uncontrolled Bundibugyo Ebolavirus outbreak in the Democratic Republic of the Congo threatens to be the largest Ebola outbreak in history. The World Health Organization has declared it a Public Health Emergency of International Concern.
Join us as for an overview of key innovations in the development of an Ebolavirus vaccine, how that knowledge is being applied to the current outbreak, and how Ebola research being conducted at JABSOM is contributing to outbreak response.
Development of vaccines and therapeutics is essential for long-term prevention and control of Ebolaviruses. Development of ERVEBO—the licensed single-dose, live-attenuated recombinant vaccine for the Zaire strain of Ebolavirus—provides important lessons on the regulatory, clinical, and development process that can be applied to the ongoing Bundibugyo outbreak and other epidemic pathogens, including the critical nature of public-private partnerships, need for innovation and coordination in clinical trial design, regulatory harmonization, and importance of community engagement. Applying this knowledge is key as the public health community comes together to address the Bundibugyo outbreak, especially given reduced investment in emerging infectious disease research and the U.S. withdrawal from the WHO.
Beth-Ann Griswold Coller is a retired pharmaceutical executive with more than 30 years of post-doctoral vaccine development experience. She worked in small biotech and large pharmaceutical firms with a particular focus on viral vaccines and vaccines for tropical diseases. She was senior vice president for research and development at Hawaii Biotech Inc. until 2010, when she joined Merck & Co., Inc., Rahway, N.J., where she led product development teams for Ebola and dengue vaccine candidates. A long-standing member of the American Society Tropical Medicine and Hygiene and the American Society for Virology, she continues to support important public health initiatives. She serves on the Scientific Advisory Committee for the Coalition for Epidemic Preparedness Innovation, leads the vaccine section update to the World Health Organization’s Filovirus Road Map, acts as an Independent Data Monitoring Committee member supporting Filovirus vaccine development for a non-profit, and serves on the Scientific Advisory Boards for two NIH-funded (Research and Development of Vaccines and Monoclonal Antibodies) programs.
Dr. Coller has more than 40 publications in peer-reviewed journals. She received her BS from Norwich Unversity, Medical Technology Certification from the University of Virginia, MS from the University of Dayton, and PhD from the University of Nebraska Medical Center.
Questions? Email arcshonolulu@gmail.com or meisuilan90@gmail.com
Parking is available in metered stalls on Ilalo and Cook Streets or Lot C ($2 per hour, cashless payment only)
Directions and parking info at https://go.hawaii.edu/p9R
| Attending in Person | $0.00 |
| Attending Online | $0.00 |
Event Info Page Settings
|
